Increased Time From Neoadjuvant Chemoradiation to Surgery Is Associated With Higher Pathologic Complete Response Rates in Esophageal Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Increased Time From Neoadjuvant Chemoradiation to Surgery Is Associated With Higher Pathologic Complete Response Rates in Esophageal Cancer

Published:2015-01 Issue:1 Volume:99 Page:270-276
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Shaikh Talha,Ruth Karen,Scott Walter J.,Burtness Barbara A.,Cohen Steven J.,Konski Andre A.,Cooper Harry S.,Astsaturov Igor,Meyer Joshua E.

Funder

National Institutes of Health

National Cancer Institute

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference21 articles.

1. Neoadjuvant treatment of advanced stage esophageal adenocarcinoma increases survival;Walsh;Dis Esophagus,2002

2. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma;Urba;J Clin Oncol,2001

3. A prospective study of combined therapy in esophageal cancer;Apinop;Hepatogastroenterology,1994

4. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: Calgb 9781;Tepper;J Clin Oncol,2008

5. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N Engl J Med,2012

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Definitive Chemoradiotherapy versus Trimodality Therapy for Locally Advanced Esophageal Adenocarcinoma: A Multi-Institutional Retrospective Cohort Study;Cancers;2024-08-15

2. Finding the Optimal Time to Esophagectomy After Systemic Therapy Would be Finding a Lost Princess or Prince;Annals of Surgical Oncology;2024-03-22

3. Optimal Time-to-Surgery Recommendations Based on Primary Tumor Volume Regression for Patients with Resectable Esophageal Cancer after Neoadjuvant Chemoradiotherapy: A Retrospective Study;Annals of Surgical Oncology;2024-01-27

4. Factors affecting timing of surgery following neoadjuvant chemoradiation for esophageal cancer;Heliyon;2023-12

5. Patient choice of surgery or surveillance following a clinical complete response to neoadjuvant chemoradiotherapy for oesophageal carcinoma;British Journal of Surgery;2023-11-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3